Shih‐Ya Hung
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- RNA modifications and cancer 5
- Heme Oxygenase-1 and Carbon Monoxide 4
- Epidemiology 12
- Autophagy in Disease and Therapy 7
- Co-authors
- Wen Fu (8 shared papers)Houng‐Chi Liou (4 shared papers)E. Maruthi Prasad (2 shared papers)Wei‐Pang Huang (2 shared papers)Yi‐Hung Chen (11 shared papers)Ming‐Wei Lin (4 shared papers)Kai‐Hsiang Kang (3 shared papers)Jan‐Gowth Chang (5 shared papers)
- Journals
- International Journal of Molecular Sciences (4 papers)Scientific Reports (2 papers)International Journal of Medical Sciences (2 papers)European Journal of Pharmacology (2 papers)Antioxidants (2 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Shih‐Ya Hung
54 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Neurology 200
- Complementary and alternative medicine 187
- Biological Psychiatry 57
- Neurology 288
- Pharmacology 292
Countries citing papers authored by Shih‐Ya Hung
This map shows the geographic impact of Shih‐Ya Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Ya Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Ya Hung more than expected).
Fields of papers citing papers by Shih‐Ya Hung
This network shows the impact of papers produced by Shih‐Ya Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Ya Hung. The network helps show where Shih‐Ya Hung may publish in the future.
Co-authors
The 25 scholars most cited alongside Shih‐Ya Hung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug candidates in clinical trials for Alzheimer’s disease Hit paper breakdown → | 2017 | 329 |
| 2 | 2009 | 160 | |
| 3 | 2008 | 117 | |
| 4 | 2019 | 93 | |
| 5 | 2020 | 76 | |
| 6 | 2013 | 74 | |
| 7 | 2021 | 73 | |
| 8 | 2003 | 69 | |
| 9 | 2014 | 66 | |
| 10 | 2009 | 63 | |
| 11 | 2009 | 61 | |
| 12 | 2013 | 53 | |
| 13 | 2017 | 51 | |
| 14 | Histone-modifying genes as biomarkers in hepatocellular carcinoma. | 2014 | 40 |
| 15 | 2015 | 34 | |
| 16 | 2011 | 34 | |
| 17 | 2016 | 33 | |
| 18 | 2019 | 30 | |
| 19 | 2013 | 27 | |
| 20 | 2013 | 27 |
About Shih‐Ya Hung
Shih‐Ya Hung is a scholar working on Molecular Biology, Epidemiology, Neurology, Physiology and Cellular and Molecular Neuroscience, having authored 55 papers that have together received 1.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (10 papers), Autophagy in Disease and Therapy (7 papers), Pain Mechanisms and Treatments (6 papers), Neuroscience and Neuropharmacology Research (6 papers), RNA modifications and cancer (5 papers), Acupuncture Treatment Research Studies (5 papers), Alzheimer's disease research and treatments (4 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). The work is most often cited by research in Neurology (200 citations), Complementary and alternative medicine (187 citations), Biological Psychiatry (57 citations), Neurology (288 citations) and Pharmacology (292 citations). Shih‐Ya Hung has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Wen Fu, Houng‐Chi Liou, E. Maruthi Prasad, Wei‐Pang Huang, Yi‐Hung Chen, Ming‐Wei Lin, Kai‐Hsiang Kang, Jan‐Gowth Chang, Chi‐Chen Lin and Ruey‐Meei Wu. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, International Journal of Medical Sciences, European Journal of Pharmacology and Antioxidants.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.